Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis
2018 · Science Advances · 58 citations
https://doi.org/10.1126/sciadv.aat3834
T
Timothy R. Hercus
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
2.4K
Citations
27
h-index
35
i10-index
Timothy R. Hercus is an academic researcher from South Australia Pathology. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & Cytokine Signaling Pathways and Interactions. The author has an h-index of 27, co-authored 110 publications.
ORCID: 0000-0001-5290-9206Papers by this author
worksCSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
2015 · mAbs · 44 citations
https://doi.org/10.1080/19420862.2015.1119352
A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
2018 · Nature Communications · 44 citations
https://doi.org/10.1038/s41467-017-02633-7
Blocking the human common beta subunit of the GM-CSF, IL-5 and IL-3 receptors markedly reduces hyperinflammation in ARDS models
2022 · Cell Death and Disease · 31 citations
https://doi.org/10.1038/s41419-022-04589-z
Figure S2 from Distinct assemblies of heterodimeric cytokine receptors govern stemness programs in leukemia
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025598.v1
Figure S3 from Distinct assemblies of heterodimeric cytokine receptors govern stemness programs in leukemia
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025595
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat